Sexual dysfunction is common in MS

4th January 2016

Sexual dysfunction is a common but often overlooked and undertreated symptom in MS

Consultant wanted: evidence review on quality of life & MS

17th December 2015

An exciting opportunity has arisen to work with us on a project to refresh 'the Principles to…

23 answers on predicting disease progression and MRI

17th December 2015

MS researcher Arman Eshaghi answers questions from around the world

Kiss Goodbye to MS goes global

10th December 2015

An exciting new international fundraising campaign for MS is coming your way

Results from a long-term observational study on MS

6th December 2015

Long-term follow-up studies could help determine predictive factors for long-term clinical outcomes

Improving clinical trial designs in MS

4th December 2015

Study suggests that longer observation time is necessary for more reliable results

Recommended treatment after stopping natalizumab

3rd December 2015

Switching from natalizumab to an alternative drug may prevent disease reactivation

Your chance to ask a young researcher about his work

3rd December 2015

Arman Eshaghi will answer your questions

New drug tested for relapsing-remitting MS

1st December 2015

Results show daclizumab to be effective in reducing relapse rate and new lesions in relapsing-remitting MS

ABEM works with Brazilian mental health initiative

28th November 2015

Brazilian MS Association ABEM is taking part in a campaign to highlight the importance of mental health…

Multiple Sclerosis Ireland launches report on the hidden costs of MS

26th November 2015

On 21st October, MS Ireland launched a report on the costs of multiple sclerosis to Irish society

Global Patient Solidarity Day & UN Day for people with Disabilities

25th November 2015

There are two World Days coming up which will be of interest to the global MS community.